Simponi Maintains Long-Term Effects in UC Patients, GO-COLITIS Results Show

Simponi Maintains Long-Term Effects in UC Patients, GO-COLITIS Results Show
Results from the GO-COLITIS clinical trial (NCT02092285) confirm that the long-term effects of Janssen Pharmaceutical’s Simponi (golimumab) were maintained in patients with ulcerative colitis (UC), according to
Subscribe or to access all post and page content.